• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性乳头状肾癌的影像学特征。

Imaging features of hereditary papillary renal cancers.

作者信息

Choyke P L, Walther M M, Glenn G M, Wagner J R, Venzon D J, Lubensky I A, Zbar B, Linehan W M

机构信息

Department of Radiology, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1182, USA.

出版信息

J Comput Assist Tomogr. 1997 Sep-Oct;21(5):737-41. doi: 10.1097/00004728-199709000-00014.

DOI:10.1097/00004728-199709000-00014
PMID:9294565
Abstract

PURPOSE

Our goal was to describe the imaging features of hereditary papillary renal cancer syndrome (HPRC), a new familial cancer syndrome.

METHOD

Members of seven kindreds with HPRC comprising 78 individuals were screened with contrast-enhanced CT and abdominal US. MRI was performed in three patients. Enhancement values and doubling times of solid masses were determined from CT scans.

RESULTS

Seventeen of 78 (22%) patients were affected. The HPRCs demonstrated lower enhancement (mean change in enhancement = 31 HU) than a comparable group of clear cell tumors (mean change in enhancement = 67 HU: p = 0.00001). The median tumor doubling time on serial CT was 18 months. The HPRCs were relatively hypovascular, enhanced uniformly, and grew slowly. Therefore, careful measurements of the region of interest should be obtained before and after intravenous administration of contrast medium. Though US detected only 45% of the lesions visualized on CT, it was useful in determining if lesions were cystic. Contrast-enhanced MRI demonstrated similar characteristics to contrast-enhanced CT.

CONCLUSION

The tumors of patients with HPRC pose some diagnostic difficulties because they can be missed by US, are small, and enhance poorly on CT. CT is preferable to US as a screening tool because of its higher sensitivity in detecting small lesions, and when contrast media cannot be administered, MR is a suitable alternative to CT.

摘要

目的

我们的目标是描述遗传性乳头状肾癌综合征(HPRC)这一新型家族性癌症综合征的影像学特征。

方法

对7个患有HPRC的家族中的78名成员进行了对比增强CT和腹部超声检查。对3例患者进行了MRI检查。从CT扫描中确定实性肿块的强化值和倍增时间。

结果

78例患者中有17例(22%)患病。HPRC的强化程度低于一组可比的透明细胞肿瘤(强化平均变化 = 31 HU)(透明细胞肿瘤强化平均变化 = 67 HU:p = 0.00001)。连续CT上肿瘤的中位倍增时间为18个月。HPRC相对血供较少,强化均匀,生长缓慢。因此,在静脉注射造影剂前后应仔细测量感兴趣区域。虽然超声仅检测到CT上显示病变的45%,但它有助于确定病变是否为囊性。对比增强MRI显示出与对比增强CT相似的特征。

结论

HPRC患者的肿瘤存在一些诊断困难,因为它们可能被超声漏诊,体积小,且在CT上强化不佳。CT作为筛查工具优于超声,因为其在检测小病变方面具有更高的敏感性,当不能使用造影剂时,MR是CT的合适替代方法。

相似文献

1
Imaging features of hereditary papillary renal cancers.遗传性乳头状肾癌的影像学特征。
J Comput Assist Tomogr. 1997 Sep-Oct;21(5):737-41. doi: 10.1097/00004728-199709000-00014.
2
Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.对比增强多期肾脏协议 CT 与 MRI 诊断乳头状肾细胞癌的比较。
AJR Am J Roentgenol. 2016 Feb;206(2):319-25. doi: 10.2214/AJR.15.14932.
3
Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters.
AJR Am J Roentgenol. 2004 Nov;183(5):1387-91. doi: 10.2214/ajr.183.5.1831387.
4
Automated noninvasive classification of renal cancer on multiphase CT.多期 CT 自动无创肾癌分类。
Med Phys. 2011 Oct;38(10):5738-46. doi: 10.1118/1.3633898.
5
Papillary renal cell carcinoma and clear cell renal cell carcinoma: Differentiation of distinct histological types with contrast - enhanced ultrasonography.乳头状肾细胞癌和透明细胞肾细胞癌:用超声造影鉴别不同组织学类型。
Eur J Radiol. 2015 Oct;84(10):1849-56. doi: 10.1016/j.ejrad.2015.06.017. Epub 2015 Jun 25.
6
Contemporary radiologic imaging of renal cortical tumors.肾皮质肿瘤的当代放射影像学
Urol Clin North Am. 2008 Nov;35(4):593-604; vi. doi: 10.1016/j.ucl.2008.07.012.
7
Papillary renal cell carcinoma: CT and sonographic evaluation.乳头状肾细胞癌:CT与超声检查评估
AJR Am J Roentgenol. 1984 Nov;143(5):1005-9. doi: 10.2214/ajr.143.5.1005.
8
Renal papillary carcinoma: CT and MRI features.肾乳头状癌:CT 和 MRI 特征。
Diagn Interv Imaging. 2014 Nov;95(11):1055-63. doi: 10.1016/j.diii.2014.03.013.
9
Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.CT 和 MRI 对乳头状肾细胞癌亚型的鉴别诊断。
AJR Am J Roentgenol. 2013 Aug;201(2):347-55. doi: 10.2214/AJR.12.9451.
10
Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.2016 年 WHO 分类时代以囊性改变为主表现的乳头状肾细胞癌的影像学特征。
Abdom Radiol (NY). 2017 Jul;42(7):1850-1856. doi: 10.1007/s00261-017-1189-1.

引用本文的文献

1
Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review.遗传性肾细胞癌中的肿瘤发生机制:综述。
Genes (Basel). 2022 Nov 15;13(11):2122. doi: 10.3390/genes13112122.
2
Early-onset renal cell carcinoma in harmatoma tumour syndrome.错构瘤肿瘤综合征中的早发性肾细胞癌
NPJ Genom Med. 2020 Sep 29;5:40. doi: 10.1038/s41525-020-00148-7. eCollection 2020.
3
Structured assessment and followup for patients with hereditary kidney tumour syndromes.遗传性肾肿瘤综合征患者的结构化评估与随访
Can Urol Assoc J. 2016 Jul-Aug;10(7-8):E214-E222. doi: 10.5489/cuaj.3798. Epub 2016 Jul 12.
4
Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.非透明细胞肾细胞癌:基于疾病的治疗管理和靶向治疗方法的机会。
Semin Oncol. 2013 Aug;40(4):511-20. doi: 10.1053/j.seminoncol.2013.05.009.
5
Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.乳头状肾细胞癌与 PTEN 错构瘤肿瘤综合征相关。
Urology. 2012 May;79(5):1187.e1-7. doi: 10.1016/j.urology.2011.12.025. Epub 2012 Mar 3.
6
Familial renal cancer: molecular genetics and surgical management.家族性肾癌:分子遗传学与外科治疗
Int J Surg Oncol. 2011;2011:658767. doi: 10.1155/2011/658767. Epub 2011 Aug 22.
7
Advances in the genetics of familial renal cancer.家族性肾癌遗传学研究进展。
Oncologist. 2010;15(6):532-8. doi: 10.1634/theoncologist.2010-0023. Epub 2010 May 19.
8
Hereditary kidney cancer: unique opportunity for disease-based therapy.遗传性肾癌:基于疾病的治疗的独特机遇。
Cancer. 2009 May 15;115(10 Suppl):2252-61. doi: 10.1002/cncr.24230.
9
The clinical implications of the genetics of renal cell carcinoma.肾细胞癌遗传学的临床意义。
Urol Oncol. 2009 Mar-Apr;27(2):131-6. doi: 10.1016/j.urolonc.2008.11.001.
10
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.肾癌的遗传基础:针对疾病的治疗方法的机遇。
Expert Opin Biol Ther. 2008 Jun;8(6):779-90. doi: 10.1517/14712598.8.6.779.